Non profit American Botanical Council has announced Horphag Research as the recipient of its annual Varro E. Tyler Commercial Investment in Phytomedicinal Research Award. “ABC congratulates Horphag Research for this most well-deserved and probably overdue honor,” said Mark Blumenthal, founder and executive director of ABC. “Horphag Research is the epitome of a research-based natural products company, investing millions of dollars in scores of clinical research trials on its key product, Pycnogenol®. I have no doubt that if he were alive today, he would fully endorse ABC’s choosing Horphag this year to receive his eponymous award,” continued Blumenthal.
The winning nomination described the ingredient in question as a true example of innovation ... and the judges clearly agreed. Tipping the scales in favour of this company's submission was "an impressive catalogue of clinical trials and regulatory compliance studies." In addition, one judge commented on the very impressive record of publications and the clearly explained ROI: 350 million dollars of global sales in 2011 and double-digit growth. Fending off particularly strong competition from Trace Minerals and Capsugel, this company aimed to set a sterling example of innovation in the marketplace ... and succeeded.
Further, Natural Health Science/Horphag Research was named the winner of the 2010 SupplySide West Scientific Excellence Award for Pycnogenol® French maritime pine bark extract . The award recognizes Pycnogenol® as one of the most innovative and researched ingredients within the nutraceutical industries. The award also acknowledges Horphag Research’s significant investment of $1.5 million a year in Pycnogenol® research over the last three years.
In recognition of Horphag Research’s strong commitment to innovative research and development of Pycnogenol®, the company was awarded the 2008 Frost & Sullivan North American Health Ingredients Excellence in Research Award. According to Frost & Sullivan analysts, «Pycnogenol® has set a new benchmark for all nutritional ingredients and dietary supplements in terms of its versatile health benefits, safety data and research portfolio and stands the highest probability of becoming an undisputed industry standard in the near future.»